Jin Rong Jie·2025-11-26 05:12Market Overview - The Hang Seng Index rose by 0.46%, gaining 119 points to reach 26,013 points, while the Hang Seng Tech Index increased by 0.51%. The morning trading volume in Hong Kong was HKD 114 billion [1] Company Performance - Meituan-W (03690) saw a morning increase of 5.85%, while Alibaba indicated a significant reduction in investment for Taobao Flash Sale expected in the next quarter [1] - Eastern Airlines (00670) experienced a rise of over 6%, benefiting from improved oil cost management [1] Biotechnology Sector - The Hang Seng Biotechnology Index increased by over 2%. Rongchang Biotech (09995) rose by over 5%, and Kangfang Biotech (09926) increased by over 4%. China Biopharmaceutical (01177) rose by 2.59% due to a significant breakthrough in HER2 dual-target ADC for breast cancer treatment [2] - Junshi Biosciences (01877) also saw an increase of over 3% as it plans to submit for listing following the successful Phase III clinical trial of Toripalimab subcutaneous injection [2] Other Notable Stocks - Basilea Pharmaceutica-B (02616) rose by over 6% after the European Commission approved a new indication for Sugliquin [3] - GDS Holdings (09698) increased by nearly 4% due to improved supply of domestic AI chips, with Morgan Stanley expecting a surge in orders in the second half of next year [3] - Longi Green Energy (06869) rose by nearly 7%, driven by interest in Google's TPU chips, with institutions optimistic about growth driven by AI data communication [3] - Smoore International (06969) increased by over 4% after signing a long-term procurement agreement for battery cells with EVE Energy to secure supply for its e-cigarette products [3] Alibaba Financial Results - Alibaba-W (09988) experienced a decline of over 2% during trading, with its adjusted net profit for the second fiscal quarter dropping by 72% year-on-year [4]